“…Given the inflammatory nature of cancer, other infectious diseases and the cytokine storm seen in COVID-19 positive patients, studies reported elevated levels of cytokines and TNF-α in severe COVID-19 cases [12][13][14][15], suggesting cancer patients can be more prone to develop COVID-19 disease. Also, various viral entry, processing and endosomal route protein were detected to be elevated in pancancer samples in comparison to their healthy control [16][17][18]. Furthermore, pan-cancer studies revealed that SARS-CoV-2 associated genes, namely ACE2, TMPRSS2, TMPRSS4, were found to be upregulated in a number of TGCA samples [4,5,19,20], indicating an interplay between cancer and SARS-CoV-2 infection.…”